Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2005, p. 5414, Vol. 43, No. 10
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.10.5414.2005
| LETTER TO THE EDITOR |
|
|
|---|
The problem with diagnosing Whipple's disease, however, lies beyond the sensitivity or speed of the PCR test used. DNA of T. whipplei has repeatedly been shown to be present in human samples from healthy people without Whipple's disease (8, 9). In our study, 4 out of 10 healthy individuals harbored DNA of T. whipplei in gingival plaque (9). Whipple's disease is thought to be caused by a not-yet-characterized immune defect rendering the host prone to the bacterium T. whipplei. The hallmark of Whipple's disease is the histopathological finding of macrophages containing diastase-resistant p-aminosalicylic acid (PAS)-positive material, which are T. whipplei bacteria or partly digested remnants thereof. In patients with Whipple's disease, tissue macrophages are unable to kill and clear T. whipplei. This deficiency in killing then causes Whipple's disease (5). The postulated immune defect can be simulated in vitro by the deactivation of human macrophages by interleukin-4; the human macrophages are then unable to kill T. whipplei (6). Therefore, histopathologic examination and staining of tissue biopsies (PAS/diastase-PAS staining) are essential for the diagnosis of Whipple's disease. The mere presence of DNA of T. whipplei, as demonstrated by PCR, without a demonstration of the macrophages harboring it, is not Whipple's disease. It remains doubtful whether clinical syndromes which are nonspecific (such as polyarthritis) plus demonstration of DNA of T. whipplei alone, without demonstration of PAS-positive macrophages (i.e., immunodeficient macrophages unable to digest T. whipplei), qualify as some kind of forme fruste of Whipple's disease (1).
|
|
|---|
|
Markus Schneemann* Gabriele Schoedon Research Unit Medical Clinic B University Hospital Rämistrasse 100 8091 Zürich, Switzerland
|
||||||
| * Phone: 41 44 255 4089, Fax: 41 44 255 4445, E-mail: markus.schneemann{at}usz.ch |
|
|
|---|
As the title of our article summarizes, the intent of our study was to compare a new PCR method, real-time PCR, to conventional PCR for detecting T. whipplei in human specimens. As we state in the Discussion, the real-time PCR method was comparable in accuracy to the conventional PCR method, but the real-time PCR method was much faster and much easier to perform. Our intent was not to prove the clinical significance of a positive PCR result for T. whipplei in human specimens.
|
Lynne M. Sloan Jon E. Rosenblatt Franklin R. Cockerill III* Division of Clinical Microbiology Department of Laboratory Medicine and Pathology Mayo Clinic-Mayo Foundation 200 First St., SW Rochester, MN 55905
| ||||||
|
* Phone: (507) 284-3697 Fax: (507) 284-4272 E-mail: cockerill.franklin{at}mayo.edu |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»